Hollysys (HOLI US): Keep Calm as Closing Date Slips

426 Views17 Apr 2024 02:14
The spread has widened to 8% due to regulatory approval concerns. Regulatory approval should be forthcoming as the transaction involves Chinese entities acquiring a Chinese-focused company.
What is covered in the Full Insight:
  • Transaction Delay Explanation
  • Closing Conditions Status
  • Chinese Regulatory Approvals Introduction
  • NDRC, MOFCOM and SAFE Procedures
  • Reasons why regulatory approvals should be forthcoming
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Arun George
IPOs and Catalysts/Events
Global Equity Research Ltd
Information TechnologyEquitiesEquity Capital MarketsEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x